In fact, a small‐molecule inhibitor targeting SOS1 was shown to inhibit growth of cancer cells with wild‐type K‐Ras, but not cells with mutant K‐Ras, including A549 (Evelyn et al., 2014). Here, KRAS is linked to cancer.